Qube Research & Technologies (QRT)
DCPH

Qube Research & Technologies (QRT)’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-242,056
Closed -$3.81M – 4928
2024
Q1 		$3.81M Buy
242,056
+122,296
+102% +$1.88M 0.01% 1389
2023
Q4 		$1.93M Buy
119,760
+44,004
+58% +$561K ﹤0.01% 1549
2023
Q3 		$964K Sell
75,756
-25,791
-25% -$356K ﹤0.01% 1745
2023
Q2 		$1.43M Buy
+101,547
New +$1.45M 0.01% 1165
2023
Q1 		– Sell
-164,226
Closed -$2.69M – 3141
2022
Q4 		$2.69M Buy
164,226
+42,710
+35% +$695K 0.01% 846
2022
Q3 		$2.25M Buy
121,516
+52,522
+76% +$824K 0.01% 881
2022
Q2 		$907K Buy
+68,994
New +$762K 0.01% 1149
2020
Q1 		– Sell
-5,304
Closed -$330K – 1775
2019
Q4 		$330K Buy
+5,304
New +$252K 0.01% 1181

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DCPH Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 242,056 shares — an estimated $3.81M sold.

Qube Research & Technologies (QRT) first reported a position in DCPH in Q4 2019 and held it in 8 quarters. The position peaked at $3.81M in Q1 2024. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 242,056 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $3.81M.
  • Qube Research & Technologies (QRT) first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3.81M in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.